肺结核影像诊断标准

2021-01-30 中华医学会放射学分会 新发传染病电子杂志.2021.6(1):1-6.

肺结核(pulmonary tuberculosis,PTB)是由结核分枝杆菌感染引起的严重危害人类健康的肺部慢性传染病,是世界公认的重大公共卫生问题,也是全球十大死亡原因之一。早期精准诊断有助于减少

中文标题:

肺结核影像诊断标准

发布日期:

2021-01-30

简要介绍:

肺结核(pulmonary tuberculosis,PTB)是由结核分枝杆菌感染引起的严重危害人类健康的肺部慢性传染病,是世界公认的重大公共卫生问题,也是全球十大死亡原因之一。早期精准诊断有助于减少肺结核的传播并降低患者发病率和病死率,因而制订肺结核影像学诊断标准意义重大。本标准基于循证医学指南及标准制定的方法学,参照2011年牛津大学循证医学中心证据分级标准和国际评估、发展和评价分级(Grades of Recommendations Assessment,Development and Evaluate,GRADE)工作组推荐意见形成的方法学,并根据2017年11月9日国家卫生和计划生育委员会发布的肺结核诊断标准,最终形成推荐意见,包括原发性肺结核、血行播散性肺结核、继发性肺结核、气管支气管结核、结核性胸膜炎的影像表现、疑似病例、影像诊断病例、确诊病例诊断标准及影像学鉴别诊断等,为肺结核的临床影像诊断和鉴别诊断提供科学依据。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=肺结核影像诊断标准_何玉麟.pdf)] GetToolGuiderByIdResponse(projectId=1, id=222571c00209218e, title=肺结核影像诊断标准, enTitle=, guiderFrom=新发传染病电子杂志.2021.6(1):1-6., authorId=0, author=, summary=肺结核(pulmonary tuberculosis,PTB)是由结核分枝杆菌感染引起的严重危害人类健康的肺部慢性传染病,是世界公认的重大公共卫生问题,也是全球十大死亡原因之一。早期精准诊断有助于减少, cover=https://img.medsci.cn/202155/1620228244334_2020535.jpg, journalId=0, articlesId=null, associationId=432, associationName=中华医学会放射学分会, associationIntro=中华医学会放射学分会是中华医学会下属的从事放射学科研和临床治疗的、非为利的全国性社会团体。放射学分会于1937年在上海成立。其宗旨是团结全国从事放射学的医学科技工作者,积极推动我国放射学的发展。, copyright=0, guiderPublishedTime=Sat Jan 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>肺结核(pulmonary tuberculosis,PTB)是由结核分枝杆菌感染引起的严重危害人类健康的肺部慢性传染病,是世界公认的重大公共卫生问题,也是全球十大死亡原因之一。早期精准诊断有助于减少肺结核的传播并降低患者发病率和病死率,因而制订肺结核影像学诊断标准意义重大。本标准基于循证医学指南及标准制定的方法学,参照2011年牛津大学循证医学中心证据分级标准和国际评估、发展和评价分级(Grades of Recommendations&nbsp;Assessment,Development and Evaluate,GRADE)工作组推荐意见形成的方法学,并根据2017年11月9日国家卫生和计划生育委员会发布的肺结核诊断标准,最终形成推荐意见,包括原发性肺结核、血行播散性肺结核、继发性肺结核、气管支气管结核、结核性胸膜炎的影像表现、疑似病例、影像诊断病例、确诊病例诊断标准及影像学鉴别诊断等,为肺结核的临床影像诊断和鉴别诊断提供科学依据。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=305, tagName=肺结核)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=305, guiderKeyword=肺结核, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4171, appHits=457, showAppHits=0, pcHits=1057, showPcHits=3714, likes=3, shares=43, comments=19, approvalStatus=1, publishedTime=Wed May 05 23:31:56 CST 2021, publishedTimeString=2021-01-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed May 05 23:24:11 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 09:16:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=肺结核影像诊断标准_何玉麟.pdf)])
肺结核影像诊断标准_何玉麟.pdf
下载请点击:
评论区 (17)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2102187, encodeId=55af210218ec7, content=确实有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=998f8445616, createdName=ms3000000885273436, createdTime=Wed Nov 23 15:58:21 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204654, encodeId=3ce312046546c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b945401957, createdName=ms1000001203941975, createdTime=Mon Mar 21 16:33:31 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067138, encodeId=bce8106e13878, content=科学的结晶, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Fri Nov 05 06:10:22 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009069, encodeId=35cc100906938, content=内容呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82255576499, createdName=秋遥mmd, createdTime=Wed Aug 18 14:28:26 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004915, encodeId=c94410049152e, content=知识需要不断更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85992784713, createdName=11796290, createdTime=Tue Aug 03 16:55:00 CST 2021, time=2021-08-03, status=1, ipAttribution=)]
    2022-11-23 ms3000000885273436

    确实有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2102187, encodeId=55af210218ec7, content=确实有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=998f8445616, createdName=ms3000000885273436, createdTime=Wed Nov 23 15:58:21 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204654, encodeId=3ce312046546c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b945401957, createdName=ms1000001203941975, createdTime=Mon Mar 21 16:33:31 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067138, encodeId=bce8106e13878, content=科学的结晶, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Fri Nov 05 06:10:22 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009069, encodeId=35cc100906938, content=内容呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82255576499, createdName=秋遥mmd, createdTime=Wed Aug 18 14:28:26 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004915, encodeId=c94410049152e, content=知识需要不断更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85992784713, createdName=11796290, createdTime=Tue Aug 03 16:55:00 CST 2021, time=2021-08-03, status=1, ipAttribution=)]
    2022-03-21 ms1000001203941975

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2102187, encodeId=55af210218ec7, content=确实有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=998f8445616, createdName=ms3000000885273436, createdTime=Wed Nov 23 15:58:21 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204654, encodeId=3ce312046546c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b945401957, createdName=ms1000001203941975, createdTime=Mon Mar 21 16:33:31 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067138, encodeId=bce8106e13878, content=科学的结晶, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Fri Nov 05 06:10:22 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009069, encodeId=35cc100906938, content=内容呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82255576499, createdName=秋遥mmd, createdTime=Wed Aug 18 14:28:26 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004915, encodeId=c94410049152e, content=知识需要不断更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85992784713, createdName=11796290, createdTime=Tue Aug 03 16:55:00 CST 2021, time=2021-08-03, status=1, ipAttribution=)]
    2021-11-05 未来将来

    科学的结晶

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2102187, encodeId=55af210218ec7, content=确实有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=998f8445616, createdName=ms3000000885273436, createdTime=Wed Nov 23 15:58:21 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204654, encodeId=3ce312046546c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b945401957, createdName=ms1000001203941975, createdTime=Mon Mar 21 16:33:31 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067138, encodeId=bce8106e13878, content=科学的结晶, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Fri Nov 05 06:10:22 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009069, encodeId=35cc100906938, content=内容呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82255576499, createdName=秋遥mmd, createdTime=Wed Aug 18 14:28:26 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004915, encodeId=c94410049152e, content=知识需要不断更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85992784713, createdName=11796290, createdTime=Tue Aug 03 16:55:00 CST 2021, time=2021-08-03, status=1, ipAttribution=)]
    2021-08-18 秋遥mmd

    内容呢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2102187, encodeId=55af210218ec7, content=确实有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=998f8445616, createdName=ms3000000885273436, createdTime=Wed Nov 23 15:58:21 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204654, encodeId=3ce312046546c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b945401957, createdName=ms1000001203941975, createdTime=Mon Mar 21 16:33:31 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067138, encodeId=bce8106e13878, content=科学的结晶, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Fri Nov 05 06:10:22 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009069, encodeId=35cc100906938, content=内容呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82255576499, createdName=秋遥mmd, createdTime=Wed Aug 18 14:28:26 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004915, encodeId=c94410049152e, content=知识需要不断更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85992784713, createdName=11796290, createdTime=Tue Aug 03 16:55:00 CST 2021, time=2021-08-03, status=1, ipAttribution=)]
    2021-08-03 11796290

    知识需要不断更新

    0

拓展阅读

肺结核影像学及分级诊断专家共识

中华医学会放射学分会(CSR,chinese society of radiology) · 2018-05-30

肺结核基层诊疗指南(2018年)

中华医学会(CMA,Chinese Medical Association) · 2019-08-30

肺结核基层合理用药指南

中华医学会(CMA,Chinese Medical Association) · 2020-10-20

抗肺结核药物临床试验技术指导原则

国家药品监督管理局药品审评中心(CDE) · 2020-12-31

流动人口肺结核患者管理指南

中国防痨协会(Chinese Antituberculosis Association) · 2021-01-30

军事飞行人员肺结核医学鉴定操作指南(2022)

空军特色医学中心 · 2022-03-31